Aicardi–Goutières syndrome and the type I interferonopathies
The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Abstract
Dissection of the genetic basis of Aicardi-Goutières syndrome has highlighted a fundamental link between nucleic acid metabolism, innate immune sensors and type I interferon induction. This had led to the concept of the human interferonopathies as a broader set of Mendelian disorders in which a constitutive upregulation of type I interferon activity directly relates to disease pathology. Here, we discuss the molecular and cellular basis of the interferonopathies, their categorization, future treatment strategies and the insights they provide into normal physiology.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ADAR edits Alu RNA51, and gain of function mutations in MDA5 suggest that RNA-sensing mechanisms are involved in some AGS cases119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“Aicardi–Goutières syndrome (AGS) is a childhood encephalopathy with similarities to SLE and strong IFN-I induction119.”
From The role of retrotransposable elements in ageing and age-associated diseases (2021) · cites this paper as [119]
In the citing paper
“In fact, hypocomplementia is a common feature of type I interferonopathies66,67”
From Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation (2017) · cites this paper as [66]
In the citing paper
“For example, deficits in RNASEH2, an enzyme responsible for removing ribonucleotides from DNA and resolving R‐loops, comprise more than half of AGS diagnoses (Crow & Manel, 2015).”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
In the citing paper
“AGS is caused by mutations in genes that regulate nucleic acid metabolism.”
From Mechanisms of DNA damage-mediated neurotoxicity in neurodegenerative disease (2022) · cites this paper as Crow & Manel, 2015
Citations
Cites
1 retracted
MAVS, cGAS, and endogenous retroviruses in T-independent B cell responses
Zeng, M., Hu, Z., Shi, X., Li, X., Zhan, X., Li, X.-D., Wang, J., Choi, J. H., Wang, K.-W., Purrington, T., et al. (2014) · Science · doi:10.1126/science.346.6216.1486 · Cited by 112
RetractedMitochondrial DNA stress primes the antiviral innate immune response
West, A. P., Khoury-Hanold, W., Staron, M., Tal, M. C., Pineda, C. M., Lang, S. M., Bestwick, M., Duguay, B. A., Raimundo, N., MacDuff, D. A., et al. (2015) · Nature · doi:10.1038/nature14156 · Cited by 1,975
SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx
Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Ségéral, E., Yatim, A., Emiliani, S., Schwartz, O., & Benkirane, M. (2011) · Nature · doi:10.1038/nature10117 · Cited by 1,511
Activated STING in a Vascular and Pulmonary Syndrome
Liu, Y., Jesus, A. A., Marrero, B., Yang, D., Ramsey, S. E., Montealegre Sanchez, G. A., Tenbrock, K., Wittkowski, H., Jones, O. Y., Kuehn, H. S., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1312625 · Cited by 1,412
Evolution and impact of subclonal mutations in chronic lymphocytic leukemia
Landau, D. A., Carter, S. L., Stojanov, P., McKenna, A., Stevenson, K., Lawrence, M. S., Sougnez, C., Stewart, C., Sivachenko, A., Wang, L., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.019 · Cited by 1,379
Trex1 prevents cell-intrinsic initiation of autoimmunity
Stetson, D. B., Ko, J. S., Heidmann, T., & Medzhitov, R. (2008) · Cell · doi:10.1016/j.cell.2008.06.032 · Cited by 1,280
Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein
Hrecka, K., Hao, C., Gierszewska, M., Swanson, S. K., Kesik-Brodacka, M., Srivastava, S., Florens, L., Washburn, M. P., & Skowronski, J. (2011) · Nature · doi:10.1038/nature10195 · Cited by 1,200
Apoptotic Caspases Suppress mtDNA-Induced STING-Mediated Type I IFN Production
White, M. J., McArthur, K., Metcalf, D., Lane, R. M., Cambier, J. C., Herold, M. J., van Delft, M. F., Bedoui, S., Lessene, G., Ritchie, M. E., et al. (2014) · Cell · doi:10.1016/j.cell.2014.11.036 · Cited by 983
Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature
Rice, G. I., Kasher, P. R., Forte, G. M. A., Mannion, N. M., Greenwood, S. M., Szynkiewicz, M., Dickerson, J. E., Bhaskar, S. S., Zampini, M., Briggs, T. A., et al. (2012) · Nature Genetics · doi:10.1038/ng.2414 · Cited by 923
Self-citationImmune Interferon in the Circulation of Patients with Autoimmune Disease
Hooks, J. J., Moutsopoulos, H. M., Geis, S. A., Stahl, N. I., Decker, J. L., & Notkins, A. L. (1979) · New England Journal of Medicine · doi:10.1056/nejm197907053010102 · Cited by 921
Research works printed but not linked: 1
- Krivine, A., Tovey, M., Taty-Taty, R. & Lebon, P. Endogenous interferon-α in newborns from HIV seropositive mothers. J. Interferon Res. 12, S151 (1992).
Cited by
Items 401–500 of 931
Naesens, L., Nemegeer, J., Roelens, F., Vallaeys, L., Meuwissen, M. E. C., Janssens, K., Verloo, P., Ogunjimi, B., Hemelsoet, D., (UD-PrOZA), P. F. U. R. D., et al. (2022) · Journal of Clinical Immunology · doi:10.1007/s10875-022-01209-5 · Cited by 24
“So far, seven single-gene inborn errors in nucleic acid metabolism or sensing are associated with the clinical phenotype of AGS: TREX1, RNASEH2A, -B and -C, SAMHD1, ADAR, and IFIH1 [6].”
Self-citationTREX1 plays multiple roles in human diseases
Wang, Q., Du, J., Hua, S., & Zhao, K. (2022) · Cellular Immunology · doi:10.1016/j.cellimm.2022.104527 · Cited by 31
Cytoplasmic DNA in cancer cells: Several pathways that potentially limit DNase2 and TREX1 activities
Anindya, R. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119278 · Cited by 26
MEF2A suppresses stress responses that trigger DDX41-dependent IFN production
Smith, J. R., Dowling, J. W., McFadden, M. I., Karp, A., Schwerk, J., Woodward, J. J., Savan, R., & Forero, A. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112805 · Cited by 28
Serum Metabolic Fingerprints Characterize Systemic Lupus Erythematosus
Li, S., Ding, H., Qi, Z., Yang, J., Huang, J., Huang, L., Zhang, M., Tang, Y., Shen, N., Qian, K., et al. (2023) · Advanced Science · doi:10.1002/advs.202304610 · Cited by 24
Kumari, P., Sood, A., Fernandes, V., Khan, I., Khatri, D. K., & Singh, S. B. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-03933-y · Cited by 27
Tsubata, T. (2019) · Immune Network · doi:10.4110/in.2019.19.e1 · Cited by 29
“These mutations cause interferonopathies including Aicardi-Goutier syndrome, in which augmented IFN-I production induces systemic inflammatory disease (27).”
BackgroundMicheletti, R. G. (2021) · Cutis · doi:10.12788/cutis.0230 · Cited by 23
Han, V. X., Mohammad, S. S., Jones, H. F., Bandodkar, S., Crow, Y. J., Dale, R. C., & AGS‐JAKi Study Group (2021) · Developmental Medicine & Child Neurology · doi:10.1111/dmcn.15025 · Cited by 23
“Aicardi–Gouti eres syndrome (AGS) is a rare autoinflammatory disorder, associated with marked morbidity and mortality.(1) The proposed pathogenesis involves endogenously-derived nucleic acid-driven innate immune activation triggering overproduction of type 1 interferons.”
BackgroundSelf-citationImplication of folate deficiency in CYP2U1 loss of function
Pujol, C., Legrand, A., Parodi, L., Lopes, P. T., Mochel, F., Saracino, D., Coarelli, G., Croon, M., Popović, M., Valet, M., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210846 · Cited by 22
Beyond autophagy: New roles for ULK1 in immune signaling and interferon responses
Saleiro, D., Kościuczuk, E. M., & Platanias, L. C. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.008 · Cited by 24
“However, constitutive IFN production can be also harmful in mammals and lead to type I interferonopathies, which are monogenic disorders characterized mostly by neurological and dermatological symptoms, such as systemic lupus erythematosus (SLE) and Aicardi-Goutières syndrome [52].”
Bone involvement in monogenic autoinflammatory syndromes
Bader‐Meunier, B., Nieuwenhove, E. V., Breton, S., & Wouters, C. H. (2017) · Rheumatology · doi:10.1093/rheumatology/kex306 · Cited by 24
Beyer, U., Brand, F. J., Martens, H. K., Weder, J., Christians, A., Elyan, N., Hentschel, B., Westphal, M., Schackert, G., Pietsch, T., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1774-y · Cited by 26
Ilik, İ., Xu, Y., Zhang, Z. Z., & Aktaş, T. (2025) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-025-00867-8 · Cited by 33
“Aicardi–Goutières syndrome is a neuro-inflammatory disease that is characterized by the mutations in more than ten genes 114 .”
Piontkivska, H., Plonski, N., Miyamoto, M. M., & Wayne, M. L. (2019) · BioEssays · doi:10.1002/bies.201800239 · Cited by 24
Davenne, T., Klintman, J., Sharma, S., Rigby, R. E., Blest, H. T. W., Cursi, C., Bridgeman, A., Dadonaite, B., Keersmaecker, K. D., Hillmen, P., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107640 · Cited by 24
G3BP1 Inhibition Alleviates Intracellular Nucleic Acid–Induced Autoimmune Responses
Cai, H., Liu, X., Zhang, F., Han, Q., Liu, Z.-S., Xue, W., Guo, Z.-L., Zhao, J., Sun, L.-M., Wang, N., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2001111 · Cited by 22
Precision medicine: The use of tailored therapy in primary immunodeficiencies
Pinto, M. V., & Neves, J. F. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1029560 · Cited by 26
“year of life and a range of extra-neurologic manifestations including vasculopathy, interstitial lung disease, hepatic disease and psoriasis (116).”
BackgroundMitochondrial dsRNA: A New DAMP for MDA5
Linder, A., & Hornung, V. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.08.019 · Cited by 22
Therapeutic landscape in systemic lupus erythematosus: mtDNA activation of the cGAS-STING pathway
Gu, X., Chen, Y., Cao, K., Tu, M., Liu, W., & Ju, J. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.112114 · Cited by 27
The prototypical interferonopathy: Aicardi‐Goutières syndrome from bedside to bench
Hofer, M. J., Modesti, N. B., Coufal, N. G., Wang, Q., Sase, S., Miner, J. J., Vanderver, A. L., & Bennett, M. L. (2024) · Immunological Reviews · doi:10.1111/imr.13413 · Cited by 26
New mosaic tiles in childhood hereditary autoinflammatory disorders
Rigante, D. (2017) · Immunology Letters · doi:10.1016/j.imlet.2017.11.013 · Cited by 22
Ivanchenko, M., Thorlacius, G. E., Hedlund, M., Ottosson, V., Meneghel, L., Björkander, S., Ossoinak, A., Tingström, J., Bremme, K. A., Sverremark‐Ekström, E., et al. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216786 · Cited by 21
Monocyte CD169 expression in COVID ‐19 patients upon intensive care unit admission
Ortillon, M., Coudereau, R., Cour, M., Rimmele, T. R., Godignon, M., Gossez, M., Yonis, H., Argaud, L., Lukaszewicz, A., Venet, F., et al. (2021) · Cytometry Part A · doi:10.1002/cyto.a.24315 · Cited by 22
“mRNA levels by molecular approach, although possible within the non-urgent context of auto-immunity, is not suitable to COVID-19 emergency due to extended time-to-results.(13,14) Alternatively, overexpression of mCD169 (siglec-1, one of ISG) by whole blood flow cytometry has been recently proposed as a sensitive and s…”
BackgroundPaludan, S. R., & Mogensen, T. H. (2021) · Current Opinion in Immunology · doi:10.1016/j.coi.2021.05.004 · Cited by 22
Deciphering the Biological Significance of ADAR1–Z-RNA Interactions
Nakahama, T., & Kawahara, Y. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111435 · Cited by 21
“Symptom onset occurs during the perinatal stage, and most patients die within 10 years after birth [53,54].”
BackgroundPathophysiological Roles of the cGAS-STING Inflammatory Pathway
Maekawa, H., Fain, M. E., & Wasano, K. (2023) · Physiology · doi:10.1152/physiol.00031.2022 · Cited by 24
The Role of Genetic Risk Factors in Pathogenesis of Childhood-Onset Systemic Lupus Erythematosus
Šestan, M., Kifer, N., Arsov, T., Cook, M., Ellyard, J. I., Vinuesa, C. G., & Jelušić, M. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45070378 · Cited by 30
“Aicardi–Goutières syndrome presents as severe encephalopathy, progressive neurological damage, basal ganglia calcifications, white matter abnormalities of the brain, and, in some cases, skin changes resembling frostbite [89,90].”
BackgroundSchmelzer, L., Smitka, M., Wolf, C., Lucas, N., Tüngler, V., Hahn, G., Tzschach, A., Donato, N. D., Lee‐Kirsch, M. A., & von der Hagen, M. (2017) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2017.11.003 · Cited by 24
“Thus, loss-of-function mutations in the genes encoding the exonuclease TREX1 (MIM*606609, AGS1), the three subunits of ribonuclease H2 (MIM*610181; AGS2, MIM*610329; AGS3, MIM*610333; AGS4), the phosphohydrolase SAMHD1 (MIM*606754, AGS5) and the adenosine deaminase ADAR (MIM*146920, AGS6) as well as gain-of-function m…”
BackgroundInfluentialA clinical score to guide in decision making for monogenic type I IFNopathies
Sönmez, H. E., Karaaslan, Ç., de Jesus, A. A., Batu, E. D., Anlar, B., Sözeri, B., Bilginer, Y., Karagüzel, D., Cağdaş, D. N., Tezcan, İ., et al. (2019) · Pediatric Research · doi:10.1038/s41390-019-0614-2 · Cited by 21
DUSP4 modulates RIG-I- and STING-mediated IRF3-type I IFN response
Jiao, H., James, S. J., Png, C. W., Cui, C., Li, H., Li, L., Chia, W. N., Min, N., Li, W., Claser, C., et al. (2024) · Cell Death and Differentiation · doi:10.1038/s41418-024-01269-7 · Cited by 21
“Furthermore, inappropriate upregulation of type I IFN activity is associated with pathogenesis of autoimmune diseases such as Aicardi – Goutières syndrome and systemic lupus erythematosus [18].”
BackgroundType I interferon signalling and interferon‐responsive microglia in health and disease
López‐Atalaya, J. P., & Bhojwani-Cabrera, A. M. (2025) · FEBS Journal · doi:10.1111/febs.70126 · Cited by 26
Analysis of clinical characteristics of children with Aicardi-Goutieres syndrome in China
Wang, W., Wang, W., He, T., Zou, L., Li, W.-D., Yu, Z., Ma, M., Yang, J., & Song, H. (2022) · World Journal of Pediatrics · doi:10.1007/s12519-022-00545-1 · Cited by 23
“AGS is a childhood autoinflammatory disease characterized by constitutive upregulation of type I interferon, referred to as type I interferonopathies [23].”
BackgroundActivation of cytosolic RNA sensors by endogenous ligands: roles in disease pathogenesis
Straub, S., & Sampaio, N. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1092790 · Cited by 21
“Aicardi-Goutières Syndrome (AGS) was the first interferonopathy to be discovered, and can arise from mutations in different components of nucleic acid metabolism and sensing pathways, leading to uncontrolled pathogenic T1-IFN production (7).”
BackgroundMicrobial pathogenesis and type III interferons
Cohen, T. S., & Parker, D. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.02.005 · Cited by 23
“The first to be identified was Aicardi–Goutières syndrome (AGS), an inflammatory disorder of the brain and skin, patients exhibit raised interferon levels and a type I IFN gene signature [45].”
Diagnosis of Aicardi‐Goutières Syndrome in Adults: A Case Series
Videira, G., Malaquias, M. J., Laranjinha, I., Martins, R. C., Taipa, R. J. F., & Magalhães, M. (2020) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12903 · Cited by 20
“encephalopathy followed by generalized dystonia, spasticity, and frequent cognitive disability.(3) Because the clinical course”
BackgroundInfluentialDAI, B., Zhang, P., Yisong, Z., Pan, C., Meng, G., Xiao, X., WU, Z., Jia, W., Zhang, J., & Zhang, L. (2016) · Oncology Reports · doi:10.3892/or.2016.4802 · Cited by 20
Kameli, R., Amanat, M., Rezaei, Z., Hosseionpour, S., Nikbakht, S., Alizadeh, H., Ashrafi, M. R., Omrani, A., Garshasbi, M., & Tavasoli, A. R. (2019) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-019-1155-9 · Cited by 20
González‐Quintial, R., Nguyen, A., Kono, D. H., Oldstone, M. B. A., Theofilopoulos, A. N., & Baccalà, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203118 · Cited by 19
Buda, G., Valdéz, R., Biagioli, G., Olivieri, F., Affranchino, N., Bouso, C., Lotersztein, V., Bogunovic, D., Bustamante, J. C., & Marti, M. A. (2020) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-020-00473-7 · Cited by 19
Garau, J., Charras, A., Varesio, C., Orcesi, S., Dragoni, F., Galli, J., Fazzi, E. M., Gagliardi, S., Pansarasa, O., Cereda, C., et al. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109299 · Cited by 18
Todd, B. P., Luo, Z., Gilkes, N., Chimenti, M. S., Peterson, Z. J., Mix, M. R., Harty, J. T., Nickl‐Jockschat, T., Ferguson, P. J., Bassuk, A. G., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01635-5 · Cited by 23
Brain calcifications and PCDH12 variants
Nicolas, G., Sánchez-Contreras, M., Ramos, E. M., de Lemos, R. R., Ferreira, J., Moura, D. A. P., Sobrido, M. J., Richard, A., Lopez, A. R., Legati, A., et al. (2017) · Neurology Genetics · doi:10.1212/nxg.0000000000000166 · Cited by 20
“Calcifications are believed to be related to increased type-I interferon response in both in utero viral infections and interferonopathies.(22) Several of these clinical presentations, including TORCH in utero infections and typical Aicardi-Goutières syndrome, are similar to the ones observed in the PCDH12 homozygous…”
ResultPeriodic fever syndromes and the autoinflammatory diseases (AIDs)
Marino, A., Tirelli, F., Giani, T., & Cimaz, R. (2019) · Journal of Translational Autoimmunity · doi:10.1016/j.jtauto.2019.100031 · Cited by 21
Neurological manifestations of autoinflammatory diseases in Chinese adult patients
Qin, W., Wu, D., Luo, Y., Zhao, M., Wang, Y., Shi, X., Zhou, L., Yu, W., Sun, Y., Wang, R., et al. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2019.12.003 · Cited by 19
Pathogenesis of Autoimmunity/Systemic Lupus Erythematosus (SLE)
Shiozawa, S. (2025) · Cells · doi:10.3390/cells14141080 · Cited by 22
“Several reports have shown that excessive type I interferon levels may cause Aicardi–Gouti è res syndrome (AGS), a disease distinct from SLE [92,93].”
Luan, C., He, Y., Liu, W., Rong, Y., Gao, J., Xu, K., Yu, H., Hu, Y., Zhang, J., Chen, K., et al. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.104895 · Cited by 20
“For example, loss-of-function mutations in TREX1, a DNA repair exonuclease that degrades cytosolic DNA, have been identified in patients with autoimmune disorders such as Aicardi–Goutières syndrome and lupus (14, 15).”
BackgroundRegulation and function of R-loops at repetitive elements
Gambelli, A., Ferrando, A., Boncristiani, C., & Schoeftner, S. (2023) · Biochimie · doi:10.1016/j.biochi.2023.08.013 · Cited by 19
‘From R-lupus to cancer’: Reviewing the role of R-loops in innate immune responses
Bradley, L., & Savage, K. I. (2023) · DNA repair · doi:10.1016/j.dnarep.2023.103581 · Cited by 19
“Aicardi-Gouti ` eres Syndrome (AGS) is a rare, inherited autoimmune disease which leads to progressive neurological damage driven by inflammation [45].”
Elevated A-to-I RNA editing in COVID-19 infected individuals
Merdler-Rabinowicz, R., Gorelik, D., Park, J., Meydan, C., Foox, J., Karmon, M., Roth, S. H., Cohen‐Fultheim, R., Shohat-Ophir, G., Eisenberg, E., et al. (2023) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqad092 · Cited by 19
“ADAR1 knockout cells exhibit early cell death ( 16 ,17 ) , and specific mutations in ADAR1 lead to Aicardi–Goutières syndrome - an autoinflammatory disorder characterized by dysregulation of IFN-I activity ( 18 ) .”
BackgroundAsano, T., Noma, K., Mizoguchi, Y., Karakawa, S., & Okada, S. (2023) · Immunological Reviews · doi:10.1111/imr.13300 · Cited by 25
Goldberg, G., Coelho, L. B. V., Mo, G., Adang, L. A., Patne, M., Chen, Z., García-Bassets, I., Mesci, P., & Muotri, A. R. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02348-w · Cited by 22
“Loss-of-function mutations in USP18 are associated with an IFN-mediated leukodystrophy, similar to AGS [70–72].”
Global huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas
Bragg, R. M., Mathews, E. W., Grindeland, A., Cantle, J. P., Howland, D., Vogt, T., & Carroll, J. B. (2024) · Life Science Alliance · doi:10.26508/lsa.202402571 · Cited by 18
“One such family of diseases—type I interferonopathies—is caused by hyperactivation of type I interferon responses secondary to deficits in nucleic acid homeostasis (42,43).”
BackgroundA human inborn error connects the α's
Meyts, I., & Casanova, J. (2016) · Nature Immunology · doi:10.1038/ni.3420 · Cited by 18
Nucleic Acid Immunity in the Pathogenesis of Cutaneous Lupus Erythematosus
Günther, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01636 · Cited by 20
“Mutations in ADAR have been described associated with discoid lupus erythematosus (41) and IFIH1 is a risk gene for SLE (42).”
BackgroundInfluentialPost-translational modification control of viral DNA sensors and innate immune signaling
Song, B., Liu, D., Greco, T. M., & Cristea, I. M. (2021) · Advances in virus research · doi:10.1016/bs.aivir.2021.03.001 · Cited by 21
“Another clinically relevant example is the loss-of-function of three prime repair exonuclease 1 (TREX1; also known as DNase III), which can lead to systemic lupus erythematosus and Aicardi–Goutieres Syndrome (AGS) (Crow and Manel, 2015; Stetson et al., 2008).”
BackgroundInfluentialViengkhou, B., White, M. Y., Cordwell, S. J., Campbell, I. L., & Hofer, M. J. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02277-x · Cited by 20
Oo, A., Zandi, K., Shepard, C., Bassit, L., Musall, K., Goh, S. L., Cho, Y., Kim, D., Schinazi, R. F., & Kim, B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101635 · Cited by 19
Karathanasis, D., Rapti, A., Nezos, A., Skarlis, C., Kilidireas, C., Mavragani, C. P., & Evangelopoulos, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898049 · Cited by 21
“, 2015), characterized by a lupus reminiscent picture with high IFN-α in peripheral blood and CSF, white matter lesions, autoantibody positivity and cytopenia (Ramantani et al., 2010; Crow and Manel, 2015; Cuadrado et al., 2015; Cattalini et al., 2016).”
BackgroundCD-NTase family member MB21D2 promotes cGAS-mediated antiviral and antitumor immunity
Liu, H., Yan, Z., Zhu, D., Xu, H., Liu, F., Chen, T., Zhang, H., Zheng, Y., Liu, B., Zhang, L., et al. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01116-1 · Cited by 18
Marguet, F., Laquerrière, A., Goldenberg, A., Guerrot, A., Quenez, O., Flahaut, P., Vanhulle, C., Dumant‐Forest, C., Charbonnier, F., Vézain, M., et al. (2016) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.37577 · Cited by 18
“AGS is an inflammatory disorder belonging to the group of type I-interferonopathies, where impaired nucleic acid metabolism or increased signaling leads to increased type I-IFN response [Crow and Manel, 2015].”
BackgroundInfluentialInherited anomalies of innate immune receptors in pediatric-onset inflammatory diseases
Picard, C., Mathieu, A., Hasan, U. A., Henry, T., Jamilloux, Y., Walzer, T., & Bélot, A. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.08.002 · Cited by 17
“These diseases can be classified both as autoinflammatory disorder and type I interferonopathy [19] (Fig.”
BackgroundFluorescence imaging of intracellular nucleases—A review
Cao, X., Sun, Y., Lü, P., & Zhao, M. (2020) · Analytica Chimica Acta · doi:10.1016/j.aca.2020.08.013 · Cited by 17
Hepatic Involvement in Aicardi-Goutières Syndrome
Gavazzi, F., Cross, Z., Woidill, S., McMann, J. M., Rand, E. B., Takanohashi, A., Ulrick, N., Justine Shults, A., Vanderver, A. L., & Adang, L. A. (2021) · Neuropediatrics · doi:10.1055/s-0040-1722673 · Cited by 20
Bianchin, M. M., & Snow, Z. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.06.032 · Cited by 18
Tissue Specificity of DNA Damage and Repair
Hoch, N. C. (2023) · Physiology · doi:10.1152/physiol.00006.2023 · Cited by 19
Ahlers, L. R. H., & Goodman, A. G. (2016) · Current Clinical Microbiology Reports · doi:10.1007/s40588-016-0043-5 · Cited by 18
Birnbaum, R., Yosha‐Orpaz, N., Yanoov‐Sharav, M., Kidron, D., Gur, H. B., Yosovich, K., Lerman‐Sagie, T., Malinger, G., & Lev, D. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.6 · Cited by 17
COVID‐19 and outbreak of chilblains: are they related?
Lesort, C., Kanitakis, J., Villani, A. P., Ducroux, E., Bouschon, P., Fattouh, K., Bensaïd, B., Danset, M., & Jullien, D. (2020) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.16779 · Cited by 17
Leveraging genetics to understand ADAR1-mediated RNA editing in health and disease
Li, J. B., & Walkley, C. R. (2025) · Nature Reviews Genetics · doi:10.1038/s41576-025-00830-5 · Cited by 27
“Mutations in ADAR1 are associated with AGS, along with mutations in other genes encoding proteins involved in handling and sensing DNA and RNA in the cytoplasm 53,54 .”
Targeting cGAS-STING signaling and cell death modes in cancer and autoimmune diseases
Zhou, J., Yang, Y., Fang, Y., Du, X., Ying, Z., & Rao, C. (2025) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2025.07.004 · Cited by 20
Recognize Yourself—Innate Sensing of Non-LTR Retrotransposons
Lagisquet, J., Zuber, K., & Gramberg, T. (2021) · Viruses · doi:10.3390/v13010094 · Cited by 20
“AGS presents itself in newborns, closely resembling a congenital viral infection, and is characterized by enhanced interferon (IFN) level in the cerebrospinal fluid, a strongly reduced life expectancy, and severe physical and mental impairments [53].”
BackgroundFenaroli, P., Rossi, G. M., Angelotti, M. L., Antonelli, G., Volpi, S., Grossi, A., Delsante, M., Lodi, L., Landini, S., Romagnani, P., et al. (2021) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2021.02.330 · Cited by 17
Molecular Pathogenic Mechanisms of Hypomyelinating Leukodystrophies (HLDs)
Torii, T., & Yamauchi, J. (2023) · Neurology International · doi:10.3390/neurolint15030072 · Cited by 18
“Other leukodystrophies, including Aicardi-Goutières syndrome (AGS) [4], Adrenoleukodystrophy (ALD) (mutation in ABCD1 (ATP binding cassette subfamily D member 1)) [5], Alexander disease (mutation in glial fibrillary acidic protein (GFAP)) [6], Canavan disease (mutation in aspartoacylase gene) [7], Cerebrotendinous xan…”
BackgroundAstrocytic RNA editing regulates the host immune response to alpha-synuclein
D’Sa, K., Choi, M. L., Wagen, A. Z., Setó‐Salvia, N., Kopach, O., Evans, J. R., Rodrigues, M., Lopez-Garcia, P., Lachica, J., Clarke, B. E., et al. (2025) · Science Advances · doi:10.1126/sciadv.adp8504 · Cited by 20
Cytoplasmic RNA quality control failure engages mTORC1-mediated autoinflammatory disease
Yang, K., Han, J., Asada, M., Gill, J. G., Park, J. Y., Sathe, M., Gattineni, J., Wright, T., Wysocki, C., de la Morena, M. T., et al. (2022) · Journal of Clinical Investigation · doi:10.1172/jci146176 · Cited by 16
“For instance, Aicardi-Goutières syndrome mutations in RNase H2 (cleaves RNA-DNA hybrids) or in adenosine deaminase acting on RNA 1 (ADAR1) invoke innate immune sensing of self-nucleic acids (DNA or RNA), leading to type I IFN signaling and systemic inflammation (13).”
BackgroundCOVID-19 Molecular Pathophysiology: Acetylation of Repurposing Drugs
Lee, J., Kanwar, B. A., Khattak, A., Balentine, J., Nguyen, N. H., Kast, R. E., Lee, C. J., Bourbeau, J., Altschuler, E. L., Sergi, C. M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113260 · Cited by 19
What can pestiviral endonucleases teach us about innate immunotolerance?
Lussi, C., & Schweizer, M. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.03.003 · Cited by 20
“AGS is caused by mutations in Trex-1, various components of the RNase H2 complex, SAMHD1, ADAR-1 and Mda-5 (for review, see e.g., [95, 109] ).”
BackgroundAlipour-Khezri, E., Moqadami, A., Vahed, S. Z., & Barzegari, A. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118790 · Cited by 22
Li, J., Zhang, F., Bian, W., Chen, Y., Liu, J., Liu, Z., Xiong, Y., & Wan, X. H. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00854-y · Cited by 15
Ling, H., Wang, L. Q., Wang, H., Wang, Q., Yang, S., Tian, T., Cui, T., Yue, S., Hou, X., Zheng, Z., et al. (2023) · Kidney International Reports · doi:10.1016/j.ekir.2023.09.014 · Cited by 15
STING-Pathway Inhibiting Nanoparticles (SPINs) as a Platform for Treatment of Inflammatory Diseases
Pastora, L. E., Namburu, N. S., Arora, K., Christov, P. P., & Wilson, J. T. (2024) · ACS Applied Bio Materials · doi:10.1021/acsabm.3c01305 · Cited by 15
Antiviral immunity backfires: Pathogenic effects of type I interferon signaling in fetal development
Casazza, R. L., & Lazear, H. M. (2018) · Science Immunology · doi:10.1126/sciimmunol.aar3446 · Cited by 14
LincRNA‐EPS impairs host antiviral immunity by antagonizing viral RNA–PKR interaction
Zhu, J., Chen, S., Sun, L., Liu, S., Bai, X., Li, D., Zhang, F., Qiao, Z., Li, L., Yao, H., et al. (2022) · EMBO Reports · doi:10.15252/embr.202153937 · Cited by 17
“However, overproduction of IFN-I and hyperactivation of IFN-a / b receptor (IFNAR) downstream signaling lead to autoimmune diseases including systemic lupus erythematosus (SLE) and Aicardi-Gouti (cid:1) eres syndrome (AGS) (Chaussabel et al , 2008; Crow & Manel, 2015).”
Interferons: Cellular and Molecular Biology of Their Actions ☆
Kalvakolanu, D. V., Nallar, S. C., & Kalakonda, S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.96116-6 · Cited by 13
Taking the STING out of TLR-driven autoimmune diseases: good, bad, or indifferent?
Pawaria, S., Sharma, S., Baum, R., Nündel, K., Busto, P., Gravallese, E. M., Fitzgerald, K. A., & Marshak‐Rothstein, A. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3mr0316-115r · Cited by 17
“More recent studies have now further implicated STING in the pathogenesis of autoinflammatory diseases resulting from the excessive accrual of endogenous DNA or DNA/RNA hybrids in the cytosol of patients and mice that lack requisite nucleases [20, 21].”
BackgroundGermline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
Eis, P. S., Bruno, C. D., Richmond, T., Koralnik, I. J., Hanson, B. A., Major, E. O., Chow, C. R., Hendel, H., Stankoff, B., Gasnault, J., et al. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00186 · Cited by 15
Deficiency of the innate immune adaptor STING promotes autoreactive T cell expansion in NOD mice
Akazawa, S., Mackin, L., Jhala, G., Fynch, S., Catterall, T., Selck, C., Graham, K. L., Krishnamurthy, B., Pappas, E. G., Kwong, C.-T. J., et al. (2021) · Diabetologia · doi:10.1007/s00125-020-05378-z · Cited by 15
Xiao, W., Feng, J., Long, H.-Y., Xiao, B., & Luo, Z.-H. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.660953 · Cited by 15
“Until now, specific mutations in seven different genes have been reported to be associated with AGS, including RNASEH2A, TREX1, ADAR, RNASEH2C, RNASEH2B, SAMHD1, and IFIH1 (Crow and Manel, 2015).”
BackgroundSpectrum of Neuroradiologic Findings Associated with Monogenic Interferonopathies
Benjamin, P., Sudhakar, S. V., D’Arco, F., Löbel, U., Carney, O., Roux, C., Boddaert, N., Hemingway, C. A., Eleftheriou, D., & Mankad, K. (2021) · American Journal of Neuroradiology · doi:10.3174/ajnr.a7362 · Cited by 15
Alternative pathways driven by STING: From innate immunity to lipid metabolism
Vila, I. K., Guha, S., Kalucka, J. M., Olagnier, D. P., & Laguette, N. (2022) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2022.08.006 · Cited by 16
Development of indole derivatives as inhibitors targeting STING-dependent inflammation
Zhou, P., Yang, G., Wang, Y., Peng, Y., Xu, L., Jiang, T., Ma, J., Dong, W., & Chen, C.-P. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118216 · Cited by 15
Opposite actions of two dsRNA-binding proteins PACT and TRBP on RIG-I mediated signaling
Vaughn, L. S., Chukwurah, E., & Patel, R. C. (2021) · Biochemical Journal · doi:10.1042/bcj20200987 · Cited by 15
Psoriasis-like skin disorder in transgenic mice expressing a RIG-I Singleton–Merten syndrome variant
Tayeh, A. A., Funabiki, M., Shimizu, S., Satoh, S., Lee, S., Iwakura, Y., Kato, H., & Fujita, T. (2020) · International Immunology · doi:10.1093/intimm/dxaa071 · Cited by 15
Chang, P.-W., Wang, J., Wang, W.-P., Huang, W., Wu, M.-H., Song, J., Chen, L., Tung, C.-W., Chi, Y., & Ueng, S. (2023) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2023.117502 · Cited by 13
Dynamic neuro-immune regulation of psychiatric risk loci in human neurons
Townsley, K. G., Lee, S. H., Williams, S., Cartwright, S., Cohen, S., Sen, A., Jia, M., Young, H. E., Dobbyn, L., Deans, M., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77114-x · Cited by 18
“…type 1 interferons, including interferon-alpha (IFN α )) mediate placental response to infectious agents and can in fl uence neurological and neurodevelopmental trajectories in humans 31 ; for example, alterations in brain development are often present in patientswithgeneticinterferonopathies 32 .”
Les interféronopathies de type I. Mise au point et revue de la littérature
Picard, C., & Bélot, A. (2016) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2016.08.016 · Cited by 15
Protective Mechanisms Against DNA Replication Stress in the Nervous System
Charlier, C. F., & Martins, R. A. P. (2020) · Genes · doi:10.3390/genes11070730 · Cited by 17
Lung involvement in monogenic interferonopathies
Cazzato, S., Omenetti, A., Ravaglia, C., & Poletti, V. E. (2020) · European Respiratory Review · doi:10.1183/16000617.0001-2020 · Cited by 21
“Growing insights were also derived from investigating the AGS molecular foundation [12], dissecting the type I IFN upregulation in monogenic forms of SLE and exploiting nucleic acid metabolism-driven IFN induction.”
Huang, Y., Liang, W. Y., Li, K., Liao, X., Chen, J., Qiu, X., Liu, K., Qiu, D., & Qin, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.07.028 · Cited by 13
Metadata
- Authors
- Crow, Y. J., & Manel, N.
- Affiliations
- Inserm (FR)
- Corresponding author
- Crow, Yanick J.
- Venue
- Nature Reviews Immunology
- Published
- 2015-06-05
- Volume
- 15
- Issue
- 7
- Pages
- 429-440
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1542158376
- Cited by
- 925
- References
- 106
- Citations by year
- 2026: 63 · 2025: 80 · 2024: 83 · 2023: 92 · 2022: 103 · 2021: 92 · 2020: 82 · 2019: 80 · 2018: 71 · 2017: 88 · 2016: 75 · 2015: 16
- FWCI
- 7.72
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- Agence Nationale de la Recherche (ANR-10-IDEX-0001, ANR-11-LABX-0043)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- Aicardi-Goutières syndrome, type I interferonopathy, type I interferon, innate immune signaling, monogenic disorders, nucleic acid metabolism, innate immune sensors, interferon induction, interferonopathies, treatment options
- MeSH terms
- Animals, Humans, Interferon Type I, Nervous System Malformations, Autoimmune Diseases of the Nervous System
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.